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ABSTRACT
Background The earliest endoscopically-evident lesion in
Crohn’s disease is the aphthous ulcer, which develops
over ectopic lymphoid tissues (ie, inducible lymphoid
follicles (ILF), tertiary lymphoid tissue (TLT)) in the
chronically inflamed intestine. ILF/TLT are induced within
effector sites by homeostatic lymphoid chemokines, but
their role in the development of intestinal ILF/TLT and in
the pathogenesis of Crohn’s disease is poorly understood.
Design Using a mouse model of Crohn’s-like ileitis
(TNFΔARE) which develops florid induction of ILF/TLT
within its terminal ileum, the contribution of the CCR7/
CCL19/CCL21 chemokine axis during the development of
TLT and its role in disease pathogenesis were assessed.
Results Both CCL19 and CCL21 were increased within
the inflamed ileum of TNFΔARE mice, which resulted in
CCR7 internalisation and impaired T cell chemotaxis. ILF/
TLT were a major source of CCL19 and CCL21 and
increased local synthesis, augmented recruitment/
retention of effector, naı¨ve and central memory T cell
subsets within the inflamed ileum. Immunoblockade of
CCR7 resulted in further effector T cell retention and
exacerbation of ileitis.
Conclusions Induction of ILF/TLT in the chronically
inflamed intestine alters the homeostatic CCL19-CCL21
lymphoid-chemokine gradient and increases recruitment/
retention of effector CCR7+ T cell subsets within the
terminal ileum, contributing to the perpetuation of
chronic inflammation. Thus, blockade of CCR7 or its
ligands might result in deleterious consequences for
subjects with chronic inflammatory diseases.
INTRODUCTION
Ectopic lymphoid tissues (tertiary lymphoid tissue
(TLT) and inducible lymphoid follicles (ILF)) are
invariably present at the base of aphthous ulcers,
the earliest endoscopically-evident lesion in Crohn’s
disease (CD).1 Furthermore, their appearance
heralds recurrent disease within the neoterminal
ileum after ilectomy.2 3 These structures have
similar architecture to that of lymphoid organs and
are induced from primordial developmentally-
determined structures called cryptopatches.1 4 The
chain of molecular events required for ectopic
lymphoid tissue development under conditions
of chronic inflammation and their role in the
pathogenesis of CD are unclear.
The recirculation of T cells to the intestine,
draining lymphatics and blood is critical for
immunosurveillance and defence. While the traf-
ficking determinants for intestinal homing have
been characterised (eg, integrin a4b7, chemokine
receptor 9), those that determine retention and
egress of intestinal T cells are less well-defined.
Chemokine receptor 7 (CCR7) is expressed by
activated dendritic cells (DCs), naïve and central
memory (TCM) T cells, all of which migrate to
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Significance of this study
What is already known about this subject?
< The earliest endoscopically-evident lesion in
Crohn’s disease is the aphthous ulcer, which
develops over ectopic lymphoid tissue.
< Molecular mechanisms underlying induction of
ectopic lymphoid tissue and their role in the
pathogenesis of inflammatory bowel disease are
poorly understood.
< While the CCR7/CCL19/CCL21 chemokine axis
regulates T cell and dendritic lymphatic homing,
their ectopic expression in non-lymphoid tissues
has been associated with lymphoid neogenesis.
What are the new findings?
< Homeostatic lymphoid chemokines CCL19/
CCL21 are upregulated in the chronically
inflamed ileum of TNFDARE mice and their
mRNA transcripts localised to inducible
lymphoid tissue.
< CCR7 is internalised by T cells infiltrating the
inflamed ileum and are thus retained within the
inflamed terminal ileum.
< Antibody blockade of CCR7 increased inhibition
of T cell egress from the inflamed intestine to
draining mesenteric lymph nodes, retention
within the ileum and exacerbation of disease.
How might it impact on clinical practice in the
foreseeable future?
< The use of CCR7-blocking reagents may prove
deleterious as therapeutics for chronic inflam-
matory diseases.
< Our data highlight the TNFDARE model of chronic
murine ileitis as a novel and unique tool to
examine further the role of ectopic lymphoid
tissue in the pathogenesis of inflammatory bowel
disease.
Inflammatory bowel disease
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lymphoid organs where its ligands CCL19 and CCL21 are
abundantly expressed. The expression of CCL19 and CCL21 is
tightly regulated within lymphoid tissues, acting as chemotactic
and retentive signals.5e7 CCL21 is also expressed by high
endothelial venules (HEV), lymphatics and lymphoid stromal
cells8 and overexpressed in a variety of autoimmune diseases.9 10
Recent evidence has highlighted a role for the ectopic expression
of lymphoid chemokines CCL19 and CCL21 in the induction of
ectopic lymphoid tissue at sites of chronic inflammation.11 12
While CCL19 and CCL21 are increased in the inflamed
intestine of patients with CD,10 13 their role and that of their
receptor CCR7 has not been evaluated in CD or in preclinical
models. In this paper we assess the contribution of CCR7 and its
ligands to the pathogenesis of CD using the TNFΔARE model of
ileitis. We first examined the expression of CCL19 and CCL21 in
the intestine, then explored whether chronic inflammation had
an effect on ligand binding and function, and finally we inves-
tigated whether ectopic lymphoid tissues were a source of both
ligands and whether their increased concentrations and antibody
blockade of their receptor (ie, CCR7) had an effect on recruitment
and/or retention of lymphocyte subsets and on disease severity.
MATERIALS AND METHODS
Mice
The B6.129S-Tnftm2Gkl/Jarn (TNFΔARE) strain has been
described previously.14 Mice were heterozygous for the
DARE mutation or wild-type (WT). CCR7-deficient mice
(B6.129P2(C)-Ccr7tm1Rfor/J) were purchased from Jackson
Laboratories (Bar Harbor, Maine, USA). Animal procedures were
approved by the Institutional Animal Care and Use Committee.
Tissue fixation, paraffin embedding and histological scoring
Terminal ilea were excised, opened longitudinally and fixed in
10% buffered formalin, embedded in paraffin, cut into 5 mm
sections and stained with haematoxylin/eosin. Histological
assessment of ileitis was performed in a blinded fashion, as
described elsewhere.15
Immunofluorescence microscopy
Terminal ilea were snap-frozen in OCT, cut into sections (7 mm),
fixed with ice-cold acetone/methanol (1:1) and incubated in
TNB blocking buffer (PerkinElmer Life Sciences, Waltham,
Massachusetts, USA). Fluorochrome-conjugated antibodies,
anti-CD11c (HL3), anti-VCAM1 (429(MVCAM.A)), anti-B220
(RA3-6B2) (BD Biosciences, San Jose, California, USA), anti-
CD33 (145-2C11), anti-IgD (11-26), anti-MHCII (M5/114.15.2)
(eBioscience, San Diego, California, USA), anti-CD4 (RM4-5),
anti-Thy1.2 (53-2.1) (Invitrogen, Carlsbad, California, USA)
were diluted in TNB buffer and incubated at 258C for 1 h or at
48C overnight. IgM was detected with either FITC-conjugated
anti-IgM (11-26) or anti-mouse IgM (II/41) (eBioscience)
followed by goat-anti-rat IgG Alexa-Fluor 555 (Invitrogen).
Lyve.1 was detected using goat polyclonal anti-mouse Lyve.1
(R&D Systems, Minneapolis, Minnesota, USA) followed by
rabbit-anti-goat IgG Alexa-Fluor 555. Images were acquired
using a Zeiss AxioImage.A1 fluorescent microscope with Axio-
vision software (Zeiss, Thornwood, New York, USA) or a Nikon
Eclipse E400 fluorescent microscope with NIS-Elements
software (Nikon, Tokyo, Japan).
Laser capture microdissection
Ectopic lymphoid aggregates were isolated from frozen 7 mm
sections of ileum from mice aged >12 weeks using an Olympus
IX81 microscope and MMI Cellcut Microdissection System with
UV-cut software. Tissues were mounted onto RNAse-free slides
(MMI, Haslett, Michigan, USA), fixed with isopropanol and
stained with haematoxylin/eosin. Samples were pooled into
RNase-free collection tubes (MMI) and RNA-extracted using an
RNeasy kit according to the manufacturer ’s instructions
(QIAGEN, Valencia, California, USA).
RNA extraction, cDNA synthesis and real-time RT-PCR
Total RNA was isolated from homogenised mouse ileum using
the RNeasy Mini Kit. RNA (500 ng) was reverse-transcribed into
cDNA with a high capacity cDNA archive kit (Applied Biosys-
tems, Foster City, California, USA). A human cDNA array was
used for assessment of human targets (TissueScan Crohn’s/
Colitis cDNAArray I, Origene, Rockville, Maryland, USA). Real-
time RT-PCR was performed using Taqman Gene Expression
Assays (Applied Biosystems) containing forward and reverse
primers and FAM-labelled MGB Taqman probes. PCR assays for
mCCL19 (Mm00839967_g1), hCCL19 (Hs00171076_m1),
mCCL21 (Mm03646971_gH), hCCL21 (Hs00171076_m1) and
mCCR7 (Mm01301785_m1) were performed using Taqman
Universal PCR Master Mix and 18 s as endogenous control.
Relative gene expression was calculated using the DDCT method
with ABI RQ software (Applied BioSystems).
Quantification of CCL19 and CCL21 by ELISA
CCL19 and CCL21 concentrations were measured by ELISA
from tissues using specific antibodies and standards (Duoset,
R&D Systems) according to the manufacturer ’s instructions.
Tissue protein concentrations were equalised using a Bradford
assay (BioRad, Hercules, California, USA).
Leucocyte isolation
Splenocytes, mesenteric lymph node (MLN) and ileal lamina
propria mononuclear cells were isolated as previously
described.14 16
Figure 1 Increased CCL19 and CCL21 mRNA transcripts in TNFDARE
mice and inflammatory bowel disease. (A, B) CCL19 and CCL21 mRNA
expression was assessed in indicated organs of TNFDARE and wild-type
(WT) mice at 10 weeks of age. *p<0.05, **p<0.01 vs WT (n¼6 mice/
strain). (C, D) CCL19 and CCL21 mRNA expression was assessed using
a cDNA array generated from human intestinal tissue. Data expressed as
mean6SEM. *p<0.05 vs normal (n¼6e17). MLN, mesenteric lymph
node.
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Flow cytometry
Cells from indicated compartments were incubated with fluo-
rescently-labelled antibodies against CD4-APC-Cy7(GK1.5),
CD103-PerCp(2E7) (Biolegend, San Diego, California, USA),
CD3-eFluor450(500A2), CD8-APC(53-6.7), CD62L-PE-Cy7
(MEL-14), CD44-FITC(IM7), CCR7-PE(4B12), MHCII-FITC
(M5/114.15.2), CD11c(N418), CD11b-eFluor(M1/70), CD45-
PerCp-Cy5.5(30-F11) (eBioscience) or corresponding isotype
controls. CCR7-deficient cells were used as controls for all
experiments. CCL19-Fc is a fusion protein bound to human Fcg
fragment (eBioscience). A PE-conjugated polyclonal anti-human
IgG (Fcg-specific) (eBioscience) served as secondary detection
reagent. Analysis was performed using a BD FACSCanto (BD
Biosciences). Further analyses were performed using FLOWJo
software (Tree Star, Ashland, Oregon, USA).
Chemotaxis assay
Anti-mouse CCR7 antibody (4B12) and recombinant mouse
CCL19 and CCL21 were from R&D Systems. Migration of
splenocytes was assessed in transwell plates (24-well; 5 mm,
Costar) according to the manufacturer ’s protocol using RPMI
1640 with 5% fetal bovine serum, 2 mmol/l L-glutamine and 1%
penicillin/streptomycin. Chemokines were added 30 min prior to
loading 13105 cells per transwell. Assays were run in duplicate
for 60 min at 378C/5% CO2 with or without preincubation with
pertussis toxin (PTX; 2 h, 500 ng/ml). Migrated cells were stained
for flow cytometry and cell numbers counted with a BD FACS
CantoII (BD Biosciences) and normalised using cell titration.
Treatment studies
Twelve-week-old TNFDARE mice received four intraperitoneal
doses (200 mg) of an isotype control (IgG2ak) or a rat/mouse
chimeric-monoclonal antibody against TNF (clone CNTO5048)
every 4 days for 2 weeks (Centocor Ortho Biotech, Horsham,
Pennsylvania, USA) or five intraperitoneal doses (200 mg) of
dexamethasone (BIMEDA-MTC Animal Health Inc, Ontario,
Canada) or vehicle control (saline) every 2 days for 10 days. Ten-
week-old TNFDARE mice received four intraperitoneal doses
(500 mg) of murine anti-CCR7 monoclonal antibody (4B12) or
rat IgG2a isotype (Amgen, Thousand Oaks, California, USA)
every 4 days for 2 weeks. Tissues were collected 24 h after the
final injection.
Statistical analysis
Statistical analyses were performed using ANOVA or a two-
tailed Student t test. Data were expressed as mean6SEM.
Statistical significance was set at p<0.05.
RESULTS
CCL19 and CCL21 mRNA transcripts are increased in the ileum
and MLN of TNFΔARE mice
mRNA transcripts in the colon, ileum, jejunum and MLN of
TNFΔARE mice were assessed at 10 weeks of age and compared
with age-matched WT mice. A significant increase in CCL19 and
CCL21 transcripts was observed in the ileum (p<0.01) and
draining MLN (p<0.05) of TNFΔARE mice compared with non-
inflamed WT controls (figure 1A,B). Thus, CCL19 and CCL21
mRNA transcripts are increased in the inflamed ileum and MLN
of TNFΔARE mice.
CCL19 and CCL21 mRNA transcripts are increased in the
intestine of patients with CD and ulcerative colitis
We then quantified their expression in intestine from patients
with inflammatory bowel disease (IBD) and normal subjects.
Figure 2 Decreased CCR7 expression
in naı¨ve TNFΔARE CD4+ and CD8+ T
cells isolated from terminal ileum. (A, B)
Flow cytometric analyses of CCR7
expression by central memory (CD62L
+/CD44+) and naı¨ve (CD62L
+/CD44) T cell subsets was
performed on cells from 10-week-old
wild-type (WT) and TNFΔARE mice.
Data expressed as mean6SEM.
*p<0.05 vs WT (n¼4 mice/strain from
three independent experiments). MLN,
mesenteric lymph node.
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A significant increase in CCL19 and CCL21 transcripts was
observed in tissue from patients with Crohn’s ileitis (p<0.05),
Crohn’s colitis (p<0.05) and ulcerative colitis (p<0.05)
(figure 1C,D). Thus, as shown previously,9 increased CCL19 and
CCL21 mRNA transcripts were observed in inflamed intestine of
patients with IBD.
CCR7 expression on T cells is underestimated when assessed by
monoclonal antibody reactivity
We then assessed the mean fluorescence intensities (MFI) for
CCR7 on T cell subsets using a widely used monoclonal anti-
body (clone 4B12). To minimise receptor internalisation,17
staining was performed on freshly isolated cells maintained
at 48C. The MFI for CCR7 was not different between
WT and TNFΔARE TCM (CD44+/CD62L+) and naïve
(CD44/CD62Lhigh) T cell subsets in spleen and MLN (p>0.05,
figure 2A,B). CCR7-deficient lymphocytes (grey histograms) and
isotype monoclonal antibody controls (data not shown) were
used as controls. Similarly, TCM cells extracted from ileum
showed no significant difference in CCR7 expression (figure 2A,
B; p>0.05). By contrast, naïve CD4+ and CD8+ Tcells revealed
a significant decrease in CCR7 MFI in TNFΔARE cells compared
with age-matched WT controls (figure 2A,B; CD4+, p<0.05;
CD8+, p<0.05). Thus, only major differences in CCR7
expression in certain cell subsets were detected by this approach.
Increased CCR7 occupancy on lamina propria T cells of
TNFΔARE mice
Chemokine receptors are internalised upon ligand binding and
recycled back to the membrane.4 17 We hypothesised that
increased ligand concentrations in inflammation might result in
receptor internalisation as, in normal mice, ligand binding was
inversely related to local ligand concentrations (see figure 1 in
online supplement). Using CCL19 bound to human Fc followed
by incubation with PE-conjugated anti-human IgG (Fcg-specific)
and CCR7-deficient cells as controls, we observed that most
T cell populations from TNFΔARE mice showed significantly
decreased ligand binding (less free CCR7) compared with
WT mice. While no difference was observed in CD4+ popula-
tions isolated from MLN (figure 3A), there was a marked
decrease in the CCL19-Fc MFI in TNFΔARE ileal cells compared
with WT mice (CD4+ TCM; p<0.001, CD4+ TNaive; p¼0.001,
figure 3A). In addition, naïve CD4+ splenocytes from TNFΔARE
mice also had significantly less CCL19-Fc binding than WT mice
(figure 3A) (CD4+ TNaive; p¼0.004), whereas expression by the
CD4+ TCM population was not significantly different (p¼0.07,
figure 3A).
Assessment of CCL19-Fc binding on CD8+ T cells revealed
a similar pattern. TNFΔARE cells bound less ligand, both TCM
(CD8+ TCM: spleen, p¼0.014, ileum; p<0.001) and naïve
subsets (CD8+ TNaive: spleen and ileum; p¼0.001, figure 3B).
Unlike the CD4+ population, TCM and naïve CD8+ T cells
isolated from MLN revealed a modest but significantly decrea-
sed binding of CCL19-Fc on TNFΔARE cells compared with WT
cells (CD8+ TCM; p¼0.03: CD8+ TNaive; p¼0.005, figure 3B).
This was also observed in MHCII+/CD11chigh antigen
presenting cells (see figure 2 in online supplement). Thus,
increased local chemokine concentrations under conditions
of chronic inflammation result in decreased receptor-ligand
reactivity.
Figure 3 Impaired CCL19 binding by
TNFΔARE CD4+ and CD8+ T cells. (A,
B) Flow cytometric analyses of CCL19
binding by central memory TCM (CD62L
+/CD44+) and naı¨ve (CD62L
+/CD44) CD4+ (A) and CD8+ (B) T
cells from 10-week-old wild-type (WT)
and TNFΔARE mice. Data expressed as
mean6SEM. *p<0.05, **p<0.01,
***p<0.001 vs WT (n¼4 mice/strain
from four independent experiments).
MLN, mesenteric lymph node.
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TNFΔARE T cells display impaired chemotaxis towards CCR7
ligands
To ascertain whether reduced reactivity towards CCL19 in
TNFΔARE mice had a functional effect on cell migration,
chemotaxis assays were performed. Splenocytes from WT and
TNFΔARE mice were freshly isolated or incubated at 378C for
16 h to allow maximum re-expression of surface CCR7. Migra-
tion of splenocytes towards CCL19 was impaired in TNFΔARE
mice compared with WT mice at 1 h (0.1 mg/ml rCCL19;
p<0.05; 1 mg/ml rCCL19; p<0.05). Chemotaxis towards rCCL21
revealed a similar deficit in TNFΔARE cells (0.1 mg/ml rCCL21;
p<0.05; 1 mg/ml rCCL21; p<0.05; figure 4A). By contrast,
incubation for 16 h at 378C in vitro away from ligand fully
restored the migratory capacity of TNFΔARE Tcells (figure 4B).
Preincubation with PTX inhibited chemotaxis of T cells isolated
from both strains but did not affect viability (figure 4A). PTX
from Bordetella pertussis irreversibly inhibits Gai proteins, so it
serves as a positive control for the G protein-coupled receptor
mechanism.
Furthermore, the time course of ligand binding confirmed an
initial deficiency by freshly isolated TNFΔARE T cells to bind
CCL19 but, between 15 min and 2 h after incubation at 378C,
ligand binding was the same in cells isolated from both strains.
Cells continued to regain ligand binding for up to 16 h in both
effector and naïve T cell subsets (see figure 3 in online supple-
ment). Thus, CCR7 expression in T cells from TNFΔARE and
WT mice is similar, but increased ligand concentrations in
TNFΔARE tissues induce receptor internalisation. However, at
the tissue level we observed increased CCR7 transcripts prob-
ably due to increased leucocyte infiltrates that express CCR7
(see figure 4 in online supplement).
Ectopic lymphoid tissues in the ileum of TNFΔARE mice result in
increased local CCL19 and CCL21
Histological analysis of ileum revealed marked induction of
ectopic lymphoid tissue in inflamed ileum by >12 weeks of age
in TNFΔARE mice, which correlated with chronic ileitis (figure 5
and supplemental figure 5). To investigate a role for CCR7
ligands in the induction of TLT, we assessed the kinetics of
CCL19 and CCL21 ileal expression in TNFΔARE and WT mice
by measuring their mRNA transcripts along the time course of
the disease. Both CCL19 and CCL21 are induced in the inflamed
terminal ileum at peak disease onset by 10 weeks of age (CCL19,
p<0.001; CCL21, p<0.001) and remain elevated during chronic
disease at 20 weeks of age (CCL19, p<0.001; CCL21, p<0.05;
figure 5A,B). As the binding of CCL19-Fc decreased in ileal
TNFΔARE T cells compared with that of cells from WT mice
(figure 3), we hypothesised that the ectopic lymphoid tissues
may be a major source of both chemokines. Indeed, both CCL19
and CCL21 protein concentrations were also increased in ileum
lysates from TNFΔARE compared with WT mice (CCL19:
13.462 vs 4.561 pg/mg, p<0.001; CCL21: 86612 vs 3466 pg/
mg, p<0.001), and regression analysis positively correlated this
ectopic increase in CCR7 ligands with an increase in the number
of ileal TLT during chronic disease (figure 5DeF).
Ectopic lymphoid tissues are a main source of ectopic CCL19
and CCL21 in the ileum of TNFΔARE mice
Immunohistochemical characterisation of ectopic lymphoid
tissues in TNFΔARE mice showed that they are composed of
CD4+ and Thy1.2+ T cell clusters around B220+ IgD+ and
IgM+ B cells. MHCII+ antigen presenting cells and CD11c+
DCs are also observed. In addition, these structures contain
VCAM1+ stroma and Lyve.1+ lymphatics (figure 6A,C, ievi).
To further localise the primary source of CCL19 and CCL21
production, we compared mRNA transcripts from the ileum of
WTand TNFΔARE mice to that of laser capture microdissected
ectopic lymphoid aggregates. CCL19 and CCL21 mRNA tran-
scripts were significantly increased in whole ileal homogenates
of TNFΔARE mice (CCL19, p<0.001; CCL21, p<0.001).
However, ectopic lymphoid aggregates contained more mRNA
transcripts of both CCL19 (p<0.05) and CCL21 (p<0.01) than
whole TNFΔARE ileum (figure 6B). Inducible lymphoid aggre-
gates are therefore a major source of CCL19 and CCL21 within
Figure 4 Impaired migratory capacity of TNFΔARE T cells is restored
after ex vivo culture. (A) Chemotaxis of freshly isolated cells from
TNFΔARE and wild-type (WT) mice T cells or (B) after 16 h ex vivo
culture towards CCR7 ligands was performed in the presence or absence
of pertussis toxin (PTX). *p<0.05 versus WT. (C) Assessment of ligand
binding kinetics following incubation at indicated time points up to 16 h.
Data expressed as mean6SEM. *p<0.05, **p<0.01 vs TNFDARE
(n¼4 mice/strain from three independent experiments).
Inflammatory bowel disease
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the ileum of TNFΔARE mice and their induction correlates with
increased concentrations of these chemokines.
Effector, central memory and naı¨ve T cell subsets accumulate
in the ileum and MLN of TNFΔARE mice
To assess whether the previous findings might play a role in the
recruitment or retention of T cells within the chronically
inflamed terminal ileum in vivo, we characterised the CD4+ and
CD8+ effector (TEM; CD44+/CD62L), central memory (TCM;
CD44+/CD62L+) and naïve (TNaive; CD44/CD62L+) T cell
subsets in the ileum and MLN of WT and TNFΔARE mice.
Histological analysis of TNFΔARE ileum revealed robust ileitis
compared with age-matched WTmice (figure 7A). Chronic ileitis
was characterised by an accumulation of T cells in the terminal
ileum of TNFΔARE mice compared with WT mice, particularly
CD4+ TEM (p<0.001) (figure 7B), CD8+ TEM (p<0.001) and
CD8+ TCM (p<0.001, figure 7C). Of note, while under
homeostatic conditions naïve T cells preferentially migrate
towards lymph nodes, in TNFΔARE mice naïve T cells were
significantly increased in the ileum compared with WT mice
(CD4+: p¼0.01, figure 7B; CD8+: p<0.01, figure 7C). Thus,
increased concentration of secondary lymphoid chemokines
appears to result in increased recruitment of naïve and TCM
T cells and retention of TEM cells within the effector site, the
terminal ileum.
The MLN also displayed a marked increase in cell counts,
predominantly with CD4+ TEM (p<0.001) and CD8+ TCM
subsets (p<0.001). CD4+ TCM (p<0.01) and CD8+ TEM
Figure 5 Ectopic expression of CCL19
and CCL21 correlates with widespread
induction of ectopic lymphoid tissue in
ileum of TNFΔARE mice. (A, B) CCL19
and CCL21 mRNA expression was
assessed along the time course of ileitis
in TNFΔARE and wild-type (WT) mice.
(Cieiii) Representative H&E
micrographs showing the presence of
inducible lymphoid follicle (arrowhead),
tertiary lymphoid tissue (TLT)
(arrowheads) and Peyer’s patch in
TNFΔARE mice at 20 weeks of age;
scale bar 500 mm. (Civ, v) Widespread
ectopic TLT development is evident in
the inflamed terminal ileum but not in
non-inflamed jejunum of TNFΔARE mice
(representative images at >12 weeks
of age); scale bar 100 mm. (D) CCR7
ligands assessed by ELISA in terminal
ileum of TNFΔARE and WT mice. (E, F)
Regression analysis correlating number
of ileal TLT with CCL19 and CCL21
protein concentrations in TNFDARE
mice. Data expressed as mean6SEM.
*p<0.05, **p<0.01 vs WT-matched
control normalised to corresponding
WT tissue (n¼3e7 mice/strain). Scale
bar 100 mm. This figure is produced in
colour in the online journaldplease visit
the website to view the colour figure.
Inflammatory bowel disease
58 Gut 2013;62:53–62. doi:10.1136/gutjnl-2011-301272
 o
n
 February 25, 2020 at M
aynooth University Library. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2011-301272 on 20 January 2012. Downloaded from 
(p<0.01) were also increased (figure 7B,C). In addition, both
CD4+ (p<0.01) and CD8+ (p<0.001) naïve T cell subsets were
increased compared with WT mice. Thus, ileitis in TNFΔARE
mice is characterised by accumulation of TEM cells and enhanced
recruitment of TCM and naïve Tcells into the terminal ileum and
MLN.
Anti-CCR7 monoclonal antibody increases tissue retention,
inhibits egress and exacerbates ileitis
To examine the effect of CCR7 antibody blockade on these cell
subsets with ileum and MLN, we administered a neutralising
monoclonal antibody (clone 4B12) or a corresponding isotype
antibody to 8-week-old TNFDARE mice. A doubling of
the number of infiltrating cells within the ileum of anti-CCR7-
treated mice occurred (10.561.03106 vs 4.860.63106,
p<0.001), with increased numbers of effector CD4+ (TEM,
p<0.001) and CD8+ (TEM, p¼0.02) populations (figure 8A,B).
MHCII+/CD11chigh antigen presenting cells were similarly
increased in the lamina propria of anti-CCR7-treated mice (see
figure 6 in online supplement). Conversely, there was a marked
depletion of total cell counts in the MLN (p<0.001), with
corresponding decreases in CD4+ subpopulations (TEM:
p<0.001; TCM: p<0.001; TNaive: p<0.001) and naive CD8+
cells (TNaive: p<0.001; figure 8C,D). In addition, anti-CCR7
monoclonal antibody treatment significantly exacerbated all
histological parameters of disease: active (3.560.1 vs 6.261.0;
p¼0.02), chronic (3.360.3 vs 6.160.6; p¼0.001), villus
(3.760.4 vs 6.760.4; p<0.001) and total histological indices
(10.660.7 vs 19.961.8; p<0.001) compared with controls
(figure 8E). Our preliminary data also suggest that genetic
deletion of CCR7 in TNFDARE mice exacerbates ileitis
(total ileal inflammatory index: DARE/CCR7+/+ 11.763 vs
DARE/CCR7/ 21.962; p¼0.02). Thus, blockade of CCR7
in TNFDARE mice inhibited lymphocyte and dendritic cell
egress from the ileum, promoted retention and exacerbated
ileitis.
Anti-TNF monoclonal antibody and dexamethasone treatment
attenuates ileitis and decreases ectopic CCL19 and CCL21
transcripts in TNFDARE mice
To examine whether CCL19/21 levels are correlated with disease
severity, we administered a neutralising murine anti-TNF
monoclonal antibody and corresponding isotype antibody,
dexamethasone or vehicle control (saline) to 8e10-week-old
TNFDARE mice. Treatment with the anti-TNF monoclonal
antibody and with dexamethasone attenuated the histological
indices (anti-TNF, p<0.001; dexamethasone, p<0.001) (figure
9A,B) and significantly reduced CCL19 (p<0.001) and CCL21
(p<0.001; figure 9C) transcripts. Thus, ileal expression of CCL19
and CCL21 correlated with inflammation.
DISCUSSION
Aphthous ulcerations herald the onset of CD and its recurrence
after surgical resection.2 3 These lesions uniformly localise to the
luminal side of TLT which develop from cryptopatches, going
through an intermediate state (ie, ILF).19 Currently, the molec-
ular determinants required for their induction in the intestine of
patients with CD are poorly understood, but the dysregulated
expression of the chemokines CCL19 and CCL21 and their
receptor CCR7 have been implicated.9
As there is widespread induction of ectopic lymphoid tissue in
the chronically inflamed terminal ileum of TNFDARE mice, we
examined the expression of lymphoid chemokines and their
receptor in this model. Transcripts for CCL19 and CCL21 were
found to be increased. We then assessed CCR7 ligand binding
using a chimeric ligand (CCL19-Fc) as a surrogate for free
receptor. Available receptor was reduced in TNFDARE mice
within most compartments assessed. To ascertain whether the
decreased ligand binding capacity had functional implications,
chemotaxis assays were performed. These confirmed that Tcells
from TNFDARE mice were impaired in their ability to migrate
towards CCR7 ligands. However, ex vivo incubation at 378C
restored their migratory capacity as CCR7 was re-expressed. We
Figure 6 CCL19 and CCL21 mRNA
transcripts in ileum of ΔARE mice
localised to tertiary lymphoid tissue
(TLT). (A) TNFΔARE mice had normal
ileal architecture at 4 weeks of age. TLT
develop between 10 and 12 weeks of
age. (B) mRNA transcripts for CCR7
ligands from microdissected ileum and
TLT. Data expressed as mean6SEM,
**p<0.01 vs wild-type (WT) ileum;
yyp<0.01 vs DARE-ileum; normalised
to corresponding WT tissue (n¼3e7
mice/strain). (Cievi)
Immunofluorescence showed that these
structures contain CD4+, Thy1.2+ T
cells, CD11c+ dendritic cells, B220+
plasma cells producing IgM and IgD,
VCAM1+ cells and Lyve.1+
lymphatics. Scale bar 100 mm. This
figure is produced in colour in the online
journaldplease visit the website to
view the colour figure.
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further identified that the ectopic lymphoid tissues (which share
multiple features with lymph nodes) were a major source of
CCL19 and CCL21 in the chronically inflamed intestine, as
mRNA transcripts were abundant within these structures and
their numbers correlated with the local protein concentrations
of both ligands. This had functional relevance for disease path-
ogenesis as effector cells and also lymphoid-homing TCM and
TNaïve were increased in the terminal ileum and MLN of
TNFDARE mice. Finally, treatment of TNFDARE mice with an
anti-CCR7 antibody resulted in Tcell retention within the ileum
and impaired egress to MLN.
CCL19 and CCL21 are produced by fibroblastic reticular cells
in T cell-rich areas of lymphoid tissues and in HEV. DCs are an
additional source of CCL19, promoting recruitment of CCR7-
expressing cells to sites of antigen presentation. Both ligands are
constitutively expressed under homeostatic conditions as they
guide DCs, naïve and TCM migration into lymph nodes and
egress of activated cells from effector sites. However, these
classically homeostatic chemokines are increased in the chroni-
cally inflamed intestine of patients with CD,9 20 which suggests
that they participate in induction and maintenance of chronic
inflammation. As in CD, the expression of both CCR7 ligands
was increased in TNFDARE mice, highlighting a potential role
for these molecules in disease pathogenesis.
CCR7 is expressed by cells that traffic to lymphoid organs
(activated DCs, naïve T cells and TCM) where CCL21 is
presented bound to glycosaminoglycans of HEV through its long
basic C-terminus tail.21 In addition, effector T cells were not
believed to express CCR7, a hypothesis challenged by simulta-
neously published studies.5 6 We have previously observed
prominent effector T cell infiltrates within the terminal ileum
and MLN of TNFDARE mice as effector cells egress via afferent
lymphatics.14 17 We therefore expected a correlative increase in
the percentage of CCR7+ T cells, but there were no differences
in most compartments and a counterintuitive decrease in CCR7
expression on Tcell subsets isolated from the ileum and MLN (as
measured by CCL19-Fc binding of free receptor) of inflamed
mice. CCR7, like other chemokine receptors, is internalised upon
ligand binding (CCL19) and incubation in a ligand-free envi-
ronment promotes receptor re-expression back to the
Figure 7 Effector, central memory and naı¨ve T cells are increased in
the ileal lamina propria and mesenteric lymph nodes (MLN) of TNFDARE
mice. (A) Histological evaluation of the ileum of TNFDARE mice showed
accumulation of leucocytes within the inflamed lamina propria. (B, C)
Flow cytometric analyses showed that effector, TCM and naı¨ve CD4+
and CD8+ T cells were recruited/retained more effectively to both
compartments of TNFDARE mice compared with wild-type (WT) mice.
Data expressed as mean6SEM. *p<0.05, **p<0.01, ***p<0.001 vs
WT (n¼6 mice/strain from three independent experiments). Scale bar
100 mm. This figure is produced in colour in the online journaldplease
visit the website to view the colour figure. Figure 8 Antibody blockade of CCR7 increases lymphocyte numbers
within the ileum, inhibits egress and exacerbates ileitis. (AeD) Eight-
week-old TNFDARE mice received isotype (IgG2a) or anti-CCR7
monoclonal antibody (aCCR7; clone 4B12). Their effect on the total cell
counts and individual lymphocyte subsets was assessed in the ileum
and mesenteric lymph nodes (MLN). (E) The severity of ileitis was
assessed as described elsewhere.18 Data expressed as mean6SEM.
*p<0.05, **p<0.01, ***p<0.001 vs IgG-treated mice (n¼6e7 mice/
strain). Representative micrographs, scale bar 100 mm. This figure is
produced in colour in the online journaldplease visit the website to view
the colour figure.
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membrane.4 22 In support of receptor internalisation, chemo-
taxis of freshly isolated TNFΔARE splenocytes was impaired.
However, following ex vivo incubation, their ability to bind
ligand and their migratory capacity was restored, supporting
re-expression of the receptor. Furthermore, there did not appear
to be inflammation-triggered differences in receptor synthesis
between WTand TNFDARE Tcells as their ability to bind ligand
equalised following ex vivo culture. Thus, receptor synthesis
does not appear to be influenced by inflammation, yet increased
concentration of ligand in the chronically inflamed terminal
ileum of TNFDARE mice clearly influenced receptor internal-
isation and recycling. These data suggest that, although there
might be impaired egress of T cells from the inflamed terminal
ileum due to increased local CCR7 ligand concentrations, Tcells
can recover from this deficit once they leave the ligand-rich
effector site. Thus, increased availability of ligands in the
inflamed ileum desensitised membrane-bound CCR7, acting as
a retention signal. Increased retention of effector cells within
chronically inflamed intestine probably contributes to the
perpetuation of chronic inflammation.
Lymphoid aggregates within the intestine predate the
appearance of the adaptive immune system and span the entire
spectrum of vertebrates.23 The human intestine contains the
entire continuum, from primordial cryptopatches to the inter-
mediate ILF and the fully developed TLT observed in CD.24
Although the role of these structures in the pathogenesis of the
disease is unknown, they may perpetuate dysregulated immune
responses.20 25 26 It is now established that the CCR7/CCL19/
CCL21 axis is critical for ILF/TLT development and maintenance
and, in previous studies, ectopic expression of CCL21 in the
thyroid and pancreas was sufficient to induce ectopic lymphoid
tissues.12 27 While the clinical evidence points to their involve-
ment during the onset and recurrence of CD, their role has not
been formally addressed in preclinical models.1 In TNFDARE
ileitis, ILF/TLTare omnipresent by 10e12 weeks of age as ileitis
becomes chronic. Unlike cryptopatches and ILF which are
present in normal mouse intestine and contain small clusters of
ckit+ lymphoid tissue inducer cells, DCs and B cells,19 28 29 the
fully developed TLT in TNFΔARE mice spanned the full width
of the ileum and were composed of B220+ B cells, CD11c+ DCs
and clusters of CD4+ Tcells, which is highly reminiscent of the
architecture of Peyer ’s patch and lymph nodes. TLT contained
markedly higher levels of CCL19 (eightfold) and CCL21 (five-
fold) transcripts than whole ileum, and the concentrations of
both ligands correlated with the number of TLT. Increased levels
of these chemokines disrupt the homeostatic lymphoid
chemokine gradient, promoting retention of effector/memory T
cell subsets within the terminal ileum and exacerbated disease.
Furthermore, antibody blockade of CCR7 in TNFDARE mice
further enhances effector T cell accumulation, decreases egress
and exacerbates ileitis.
Taken together, our studies show that, in chronic ileitis, there
is widespread induction of ectopic lymphoid tissue within the
chronically inflamed terminal ileum. The proliferation of these
structures results in increased local production of CCL19 and
CCL21 and disruption of the physiological chemokine-receptor
gradient. This desensitises infiltrating CCR7+ effector memory
T cells and augments their retention in the inflamed intestine,30
which contributes to the perpetuation of ileitis. Our work
highlights a critical role of the CCR7/CCL19/CCL21 chemokine
axis during T cell recirculation under conditions of chronic
inflammation in the intestine and brings into question the
utility of antagonising CCR7 as a strategy for the treatment of
IBD or other chronic inflammatory diseases.
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